{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-tumor", "oleanolic acid", "pentacyclic triterpenoids", "water solubility"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36362079", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "11", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "31"}], "Language": ["eng"], "ELocationID": ["13291", "10.3390/ijms232113291"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "21", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "31"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Enhanced Water Solubility and Anti-Tumor Activity of Oleanolic Acid through Chemical Structure Modification.", "Abstract": {"AbstractText": ["Cancer has been a major health problem in the world in the past decades. It is urgent to develop new, effective and safe drugs for the treatment of cancer. There are many pentacyclic triterpenoids with positive anti-tumor activity and safety in nature. Oleanolic acid (OA), as one of the pentacyclic triterpenoids, also has broad biological activities including liver protection, anti-inflammatory, hypoglycemic, antiviral and anti-tumor. Therefore, to investigate its anti-tumor activity and mechanism, many OA derivatives have been developed. Some derivatives are less toxic to normal hepatocytes, which may be due to the strong liver protection ability of OA. However, the poor water solubility of OA is one of the main reasons for the weak anti-tumor activity. It is reported that some OA derivatives could enhance solubility by chemically linking some hydrophilic groups to improve anti-tumor activity. This review not only summarizes the highly water-soluble OA derivatives that can improve anti-tumor activity reported in recent years, but also introduces their possible anti-tumor mechanisms."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Gu", "ForeName": "Zhicheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Lin", "ForeName": "Shuxian", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Yan", "ForeName": "Wanli", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Chen", "ForeName": "Di", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zeng", "ForeName": "Ziwei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Chen", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "He", "ForeName": "Bin", "Initials": "B"}], "GrantList": [{"GrantID": "81960628 and 82160655", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "GCC[2022]030-1, ZK[2022]035, [2020]1Y395 and [2020]4Y206", "Agency": "Guizhou Science and Technology Department of China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "059QF0KO0R", "NameOfSubstance": "Water"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": [], "DescriptorName": "Solubility"}, {"QualifierName": ["chemistry"], "DescriptorName": "Triterpenes"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Water"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hassannia B., Vandenabeele P., Berghe T.V. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35:830\u2013849. doi: 10.1016/j.ccell.2019.04.002.", "ArticleIdList": ["10.1016/j.ccell.2019.04.002", "31105042"]}, {"Citation": "Dagogo-Jack I., Shaw A.T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 2018;15:81\u201394. doi: 10.1038/nrclinonc.2017.166.", "ArticleIdList": ["10.1038/nrclinonc.2017.166", "29115304"]}, {"Citation": "Liu Y., Yang S., Wang K., Lu J., Bao X., Wang R., Qiu Y., Wang T., Yu H. Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products. Cell Prolif. 2020;53:e12894. doi: 10.1111/cpr.12894.", "ArticleIdList": ["10.1111/cpr.12894", "PMC7574878", "32881115"]}, {"Citation": "Wang J.J., Lei K.F., Han F. Tumor microenvironment: Recent advances in various cancer treatments. Eur. Rev. Med. Pharmacol. Sci. 2018;22:3855\u20133864.", "ArticleIdList": ["29949179"]}, {"Citation": "Behranvand N., Nasri F., Emameh R.Z., Khani P., Hosseini A., Garssen J., Falak R. Chemotherapy: A double-edged sword in cancer treatment. Cancer Immunol. Immunother. 2022;71:507\u2013526. doi: 10.1007/s00262-021-03013-3.", "ArticleIdList": ["10.1007/s00262-021-03013-3", "34355266"]}, {"Citation": "Chakraborty C., Sharma A.R., Sharma G., Sarkar B.K., Lee S.-S. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget. 2018;9:10164\u201310174. doi: 10.18632/oncotarget.24309.", "ArticleIdList": ["10.18632/oncotarget.24309", "PMC5839381", "29515800"]}, {"Citation": "Fu R.G., Sun Y., Sheng W.B., Liao D.F. Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. Eur. J. Med. Chem. 2017;136:195\u2013211. doi: 10.1016/j.ejmech.2017.05.016.", "ArticleIdList": ["10.1016/j.ejmech.2017.05.016", "28494256"]}, {"Citation": "Luo B., Song X. A comprehensive overview of \u03b2-carbolines and its derivatives as anticancer agents. Eur. J. Med. Chem. 2021;224:113688. doi: 10.1016/j.ejmech.2021.113688.", "ArticleIdList": ["10.1016/j.ejmech.2021.113688", "34332400"]}, {"Citation": "Fabio G.D., Romanucci V., De Marco A., Zarrelli A. Triterpenoids from Gymnema sylvestre and their pharmacological activities. Molecules. 2014;19:10956\u201310981. doi: 10.3390/molecules190810956.", "ArticleIdList": ["10.3390/molecules190810956", "PMC6270848", "25072200"]}, {"Citation": "Ghante M.H., Jamkhande P.G. Role of Pentacyclic Triterpenoids in Chemoprevention and Anticancer Treatment: An Overview on Targets and Underling Mechanisms. J. Pharmacopunct. 2019;22:55\u201367. doi: 10.3831/KPI.201.22.007.", "ArticleIdList": ["10.3831/KPI.201.22.007", "PMC6645347", "31338244"]}, {"Citation": "Sheng H., Sun H. Synthesis, biology and clinical significance of pentacyclic triterpenes: A multi-target approach to prevention and treatment of metabolic and vascular diseases. Nat. Prod. Rep. 2011;28:543\u2013593. doi: 10.1039/c0np00059k.", "ArticleIdList": ["10.1039/c0np00059k", "21290067"]}, {"Citation": "\u017bwawiak J., Pawe\u0142czyk A., Olender D., Zaprutko L. Structure and Activity of Pentacyclic Triterpenes Codrugs. A Review. Mini. Rev. Med. Chem. 2021;21:1509\u20131526. doi: 10.2174/1389557521666210105110848.", "ArticleIdList": ["10.2174/1389557521666210105110848", "33402080"]}, {"Citation": "Yadav P., Jaswal V., Sharma A., Kashyap D., Tuli H.S., Garg V.K., Das S.K., Srinivas R. Celastrol as a pentacyclic triterpenoid with chemopre-ventive properties. Pharm. Pat. Anal. 2018;7:155\u2013167. doi: 10.4155/ppa-2017-0035.", "ArticleIdList": ["10.4155/ppa-2017-0035", "29882724"]}, {"Citation": "J\u00e4ger S., Trojan H., Kopp T., Laszczyk M.N., Scheffler A. Pentacyclic triterpene distribution in various plants\u2014Rich sources for a new group of multi-potent plant extracts. Molecules. 2009;14:2016\u20132031. doi: 10.3390/molecules14062016.", "ArticleIdList": ["10.3390/molecules14062016", "PMC6254168", "19513002"]}, {"Citation": "Siddique H.R., Saleem M. Beneficial health effects of lupeol triterpene: A review of preclinical studies. Life Sci. 2011;88:285\u2013293. doi: 10.1016/j.lfs.2010.11.020.", "ArticleIdList": ["10.1016/j.lfs.2010.11.020", "21118697"]}, {"Citation": "Sharma H., Kumar P., Deshmukh R.R., Bishayee A., Kumar S. Pentacyclic triterpenes: New tools to fight metabolic syndrome. Phytomedicine. 2018;50:166\u2013177. doi: 10.1016/j.phymed.2018.09.011.", "ArticleIdList": ["10.1016/j.phymed.2018.09.011", "30466975"]}, {"Citation": "Dzubak P., Hajduch M., Vydra D., Hustova A., Kvasnica M., Biedermann D., Markova L., Urban M., Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 2006;23:394\u2013411. doi: 10.1039/b515312n.", "ArticleIdList": ["10.1039/b515312n", "16741586"]}, {"Citation": "Vald\u00e9s K., Morales J., Rodr\u00edguez L., G\u00fcnther G. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments. Nanomedicine. 2016;11:3139\u20133156. doi: 10.2217/nnm-2016-0251.", "ArticleIdList": ["10.2217/nnm-2016-0251", "27809705"]}, {"Citation": "Zhang Q., Chang Z., Wang Q. Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice. Cardiovasc. Drugs Ther. 2006;20:349\u2013357. doi: 10.1007/s10557-006-0509-4.", "ArticleIdList": ["10.1007/s10557-006-0509-4", "17136324"]}, {"Citation": "Ukiya M., Akihisa T., Tokuda H., Suzuki H., Mukainaka T., Ichiishi E., Yasukawa K., Kasahara Y., Nishino H. Constituents of Compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett. 2002;177:7\u201312. doi: 10.1016/S0304-3835(01)00769-8.", "ArticleIdList": ["10.1016/S0304-3835(01)00769-8", "11809525"]}, {"Citation": "Khwaza V., Mlala S., Oyedeji O.O., Aderibigbe B.A. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery. Molecules. 2021;26:2401. doi: 10.3390/molecules26092401.", "ArticleIdList": ["10.3390/molecules26092401", "PMC8122576", "33918996"]}, {"Citation": "Furtado N.A.J.C., Pirson L., Edelberg H., Miranda L.M., Loira-Pastoriza C., Preat V., Larondelle Y., Andr\u00e9 C.M. Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies. Molecules. 2017;22:400. doi: 10.3390/molecules22030400.", "ArticleIdList": ["10.3390/molecules22030400", "PMC6155290", "28273859"]}, {"Citation": "P\u00e1dua T.A., de Abreu B.S., Costa T.E., Nakamura M.J., Valente L.M., Henriques M.D.G., Siani A.C., Rosas E.C. Anti-inflammatory effects of methyl ursolate obtained from a chemically derived crude extract of apple peels: Potential use in rheumatoid arthritis. Arch. Pharm. Res. 2014;37:1487\u20131495. doi: 10.1007/s12272-014-0345-1.", "ArticleIdList": ["10.1007/s12272-014-0345-1", "24733672"]}, {"Citation": "Cichewicz R.H., Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 2004;24:90\u2013114. doi: 10.1002/med.10053.", "ArticleIdList": ["10.1002/med.10053", "14595673"]}, {"Citation": "Alqahtani A., Hamid K., Kam A., Wong K.H., Abdelhak Z., Razmovski-Naumovski V., Chan K., Li K.M., Groundwater P.W., Li G.Q. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr. Med. Chem. 2013;20:908\u2013931.", "ArticleIdList": ["23210780"]}, {"Citation": "Zhu Y., Guan Y.-J., Chen Q.-Z., Yuan L.-H., Xu Q.-Q., Zhou M.-L., Liu H., Lin W., Zhang Z.-D., Zhou Z.-L., et al. Pentacyclic Triterpenes from the resin of Liquidambar formosana have anti-angiogenic properties. Phytochemistry. 2021;184:112676. doi: 10.1016/j.phytochem.2021.112676.", "ArticleIdList": ["10.1016/j.phytochem.2021.112676", "33556839"]}, {"Citation": "Pollier J., Goossens A. Oleanolic acid. Phytochemistry. 2012;77:10\u201315. doi: 10.1016/j.phytochem.2011.12.022.", "ArticleIdList": ["10.1016/j.phytochem.2011.12.022", "22377690"]}, {"Citation": "Kashyap D., Sharma A., STuli H., Punia S., KSharma A. Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities. Recent Pat. Inflamm. Allergy Drug Discov. 2016;10:21\u201333. doi: 10.2174/1872213X10666160711143904.", "ArticleIdList": ["10.2174/1872213X10666160711143904", "27531153"]}, {"Citation": "Liu J., Lu Y.-F., Wu Q., Xu S.-F., Shi F.-G., Klaassen C.D. Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses. Liver Int. 2019;39:427\u2013439. doi: 10.1111/liv.13940.", "ArticleIdList": ["10.1111/liv.13940", "30079536"]}, {"Citation": "Baer-Dubowska W., Naro\u017cna M., Krajka-Ku\u017aniak V. Anti-cancer potential of synthetic oleanolic acid derivatives and their conjugates with NSAIDs. Molecules. 2021;26:4957. doi: 10.3390/molecules26164957.", "ArticleIdList": ["10.3390/molecules26164957", "PMC8398353", "34443544"]}, {"Citation": "Oboh M., Govender L., Siwela M., Mkhwanazi B.N. Anti-diabetic potential of plant-based pentacyclic triterpene derivatives: Progress made to improve efficacy and bioavailability. Molecules. 2021;26:7243. doi: 10.3390/molecules26237243.", "ArticleIdList": ["10.3390/molecules26237243", "PMC8659003", "34885816"]}, {"Citation": "Guo T., Liu Q., Wang P., Zhang L., Zhang W., Li Y. Facile synthesis of three bidesmosidic oleanolic acid saponins with strong inhibitory activity on pancreatic lipase. Carbohydr. Res. 2009;344:1167\u20131174. doi: 10.1016/j.carres.2009.04.024.", "ArticleIdList": ["10.1016/j.carres.2009.04.024", "19463989"]}, {"Citation": "Feng A., Yang S., Sun Y., Zhang L., Bo F., Li L. Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives. BioMed Res. Int. 2020;2020:1308749. doi: 10.1155/2020/1308749.", "ArticleIdList": ["10.1155/2020/1308749", "PMC7710427", "33299854"]}, {"Citation": "Cao F., Jia J., Yin Z., Gao Y., Sha L., Lai Y., Ping Q., Zhang Y. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: Synthesis, intestinal permeability and pharmacokinetics. Mol. Pharm. 2012;9:2127\u20132135. doi: 10.1021/mp200447r.", "ArticleIdList": ["10.1021/mp200447r", "22352697"]}, {"Citation": "Fang L., Wang M., Gou S., Liu X., Zhang H., Cao F. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting anti-tumor prodrugs. J. Med. Chem. 2014;57:1116\u20131120. doi: 10.1021/jm401634d.", "ArticleIdList": ["10.1021/jm401634d", "24422538"]}, {"Citation": "Han S.I., Kim Y.S., Kim T.H. Role of apoptotic and necrotic cell death under physiologic conditions. BMB Rep. 2008;41:1\u201310. doi: 10.5483/BMBRep.2008.41.1.001.", "ArticleIdList": ["10.5483/BMBRep.2008.41.1.001", "18304444"]}, {"Citation": "Jeong D.W., Kim Y.H., Kim H.H., Ji H.Y., Yoo S.D., Choi W.R., Lee S.M., Han C.K., Lee H.S. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm. Drug Dispos. 2007;28:51\u201357. doi: 10.1002/bdd.530.", "ArticleIdList": ["10.1002/bdd.530", "17163409"]}, {"Citation": "Liby K.T., Sporn M.B. Synthetic oleanane triterpenoids: Multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol. Rev. 2012;64:972\u20131003. doi: 10.1124/pr.111.004846.", "ArticleIdList": ["10.1124/pr.111.004846", "PMC3462991", "22966038"]}, {"Citation": "Castellano J.M., Ramos-Romero S., Perona J.S. Oleanolic Acid: Extraction, Characterization and Biological Activity. Nutrients. 2022;14:623. doi: 10.3390/nu14030623.", "ArticleIdList": ["10.3390/nu14030623", "PMC8838233", "35276982"]}, {"Citation": "Tang Z.-Y., Li Y., Tang Y.-T., Ma X.-D., Tang Z.-Y. Anticancer activity of oleanolic acid and its derivatives: Recent advances in evidence, target profiling and mechanisms of action. Biomed. Pharmacother. 2022;145:112397. doi: 10.1016/j.biopha.2021.112397.", "ArticleIdList": ["10.1016/j.biopha.2021.112397", "34798468"]}, {"Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Ucker D.S., Levine J.S. Exploitation of Apoptotic Regulation in Cancer. Front. Immunol. 2018;9:241. doi: 10.3389/fimmu.2018.00241.", "ArticleIdList": ["10.3389/fimmu.2018.00241", "PMC5835066", "29535707"]}, {"Citation": "Hashemi Goradel N., Najafi M., Salehi E., Farhood B., Mortezaee K. Cyclooxygenase-2 in cancer: A review. J. Cell Physiol. 2019;234:5683\u20135699. doi: 10.1002/jcp.27411.", "ArticleIdList": ["10.1002/jcp.27411", "30341914"]}, {"Citation": "Wang X., Bai H., Zhang X., Liu J., Cao P., Liao N., Zhang W., Wang Z., Hai C. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Carcinogenesis. 2013;34:1323\u20131330. doi: 10.1093/carcin/bgt058.", "ArticleIdList": ["10.1093/carcin/bgt058", "23404993"]}, {"Citation": "Al-Alem L.F., Baker A.T., Pandya U.M., Eisenhauer E.L., Rueda B.R. Understanding and Targeting Apoptotic Pathways in Ovarian Cancer. Cancers. 2019;11:1631. doi: 10.3390/cancers11111631.", "ArticleIdList": ["10.3390/cancers11111631", "PMC6893837", "31652965"]}, {"Citation": "Maddika S., Ande S.R., Panigrahi S., Paranjothy T., Weglarczyk K., Zuse A., Eshraghi M., Manda K.D., Wiechec E., Los M. Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy. Drug Resist. Updates. 2007;10:13\u201329. doi: 10.1016/j.drup.2007.01.003.", "ArticleIdList": ["10.1016/j.drup.2007.01.003", "17303468"]}, {"Citation": "Cory S., Adams J.M. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2002;2:647\u2013656. doi: 10.1038/nrc883.", "ArticleIdList": ["10.1038/nrc883", "12209154"]}, {"Citation": "Duan L., Yang Z., Jiang X., Zhang J., Guo X. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A. Anticancer Drugs. 2019;30:812\u2013820. doi: 10.1097/CAD.0000000000000777.", "ArticleIdList": ["10.1097/CAD.0000000000000777", "30882397"]}, {"Citation": "Shyu M.H., Kao T.C., Yen G.C. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J. Agric. Food Chem. 2010;58:6110\u20136118. doi: 10.1021/jf100574j.", "ArticleIdList": ["10.1021/jf100574j", "20415421"]}, {"Citation": "Xu F., Na L., Li Y., Chen L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci. 2020;10:54. doi: 10.1186/s13578-020-00416-0.", "ArticleIdList": ["10.1186/s13578-020-00416-0", "PMC7110906", "32266056"]}, {"Citation": "Dent P. Crosstalk between ERK, AKT, and cell survival. Cancer Biol. Ther. 2014;15:245\u2013246. doi: 10.4161/cbt.27541.", "ArticleIdList": ["10.4161/cbt.27541", "PMC3974823", "24424114"]}, {"Citation": "Li X., Song Y., Zhang P., Zhu H., Chen L., Xiao Y., Xing Y. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway. Tumor Biol. 2016;37:7599\u20137613. doi: 10.1007/s13277-015-4655-9.", "ArticleIdList": ["10.1007/s13277-015-4655-9", "26687646"]}, {"Citation": "Li L., Wei L., Shen A., Chu J., Lin J., Peng J. Oleanolic acid modulates multiple intracellular targets to inhibit colorectal cancer growth. Int. J. Oncol. 2015;47:2247\u20132254. doi: 10.3892/ijo.2015.3198.", "ArticleIdList": ["10.3892/ijo.2015.3198", "26459864"]}, {"Citation": "Poto\u010dnjak I., \u0160imi\u0107 L., Vukeli\u0107 I., Bati\u010di\u0107 L., Domitrovi\u0107 R. Oleanolic acid induces HCT116 colon cancer cell death through the p38/FOXO3a/Sirt6 pathway. Chem.-Biol. Interact. 2022;363:110010. doi: 10.1016/j.cbi.2022.110010.", "ArticleIdList": ["10.1016/j.cbi.2022.110010", "35690101"]}, {"Citation": "Msibi Z.N.P., Mabandla M.V. Oleanolic Acid Mitigates 6-Hydroxydopamine Neurotoxicity by Attenuating Intracellular ROS in PC12 Cells and Striatal Microglial Activation in Rat Brains. Front. Physiol. 2019;10:1059. doi: 10.3389/fphys.2019.01059.", "ArticleIdList": ["10.3389/fphys.2019.01059", "PMC6712087", "31496954"]}, {"Citation": "Onorati A.V., Dyczynski M., Ojha R., Amaravadi R.K. Targeting autophagy in cancer. Cancer. 2018;124:3307\u20133318. doi: 10.1002/cncr.31335.", "ArticleIdList": ["10.1002/cncr.31335", "PMC6108917", "29671878"]}, {"Citation": "Levy J.M., Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol. Ther. 2011;131:130\u2013141. doi: 10.1016/j.pharmthera.2011.03.009.", "ArticleIdList": ["10.1016/j.pharmthera.2011.03.009", "PMC3539744", "21440002"]}, {"Citation": "Alzahrani A.S. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. Semin. Cancer. Biol. 2019;59:125\u2013132. doi: 10.1016/j.semcancer.2019.07.009.", "ArticleIdList": ["10.1016/j.semcancer.2019.07.009", "31323288"]}, {"Citation": "Wu X.L., Wang L.K., Yang D.D., Qu M., Yang Y.J., Guo F., Han L., Xue J. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-\u03b2/PI3K-AKT-mTOR signaling pathway. J. Cell. Biochem. 2018;119:2356\u20132367. doi: 10.1002/jcb.26399.", "ArticleIdList": ["10.1002/jcb.26399", "28884839"]}, {"Citation": "Shi Y., Song Q., Hu D., Zhuang X., Yu S., Teng D. Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway. Korean J. Physiol. Pharmacol. 2016;20:237\u2013243. doi: 10.4196/kjpp.2016.20.3.237.", "ArticleIdList": ["10.4196/kjpp.2016.20.3.237", "PMC4860365", "27162477"]}, {"Citation": "Lee J.-H., Yoo E.-S., Han S.-H., Jung G.-H., Han E.-J., Jung S.-H., Kim B.S., Cho S.-D., Nam J.-S., Choi C., et al. Oleanolic acid induces apoptosis and autophagy via the PI3K/AKT/mTOR pathway in AGS human gastric cancer cells. J. Funct. Foods. 2021;87:104854. doi: 10.1016/j.jff.2021.104854.", "ArticleIdList": ["10.1016/j.jff.2021.104854"]}, {"Citation": "Howell J.J., Ricoult S.J., Ben-Sahra I., Manning B.D. A growing role for mTOR in promoting anabolic metabolism. Biochem. Soc. Trans. 2013;41:906\u2013912. doi: 10.1042/BST20130041.", "ArticleIdList": ["10.1042/BST20130041", "23863154"]}, {"Citation": "Bu H., Liu D., Zhang G., Chen L., Song Z. AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells. OncoTargets Ther. 2020;13:8533\u20138545. doi: 10.2147/OTT.S262022.", "ArticleIdList": ["10.2147/OTT.S262022", "PMC7457577", "32904616"]}, {"Citation": "Hu C., Cao Y., Li P., Tang X., Yang M., Gu S., Xiong K., Li T., Xiao T. Oleanolic Acid Induces Autophagy and Apoptosis via the AMPK-mTOR Signaling Pathway in Colon Cancer. J. Oncol. 2021;2021:8281718. doi: 10.1155/2021/8281718.", "ArticleIdList": ["10.1155/2021/8281718", "PMC8310446", "34326874"]}, {"Citation": "Scherz-Shouval R., Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007;17:422\u2013427. doi: 10.1016/j.tcb.2007.07.009.", "ArticleIdList": ["10.1016/j.tcb.2007.07.009", "17804237"]}, {"Citation": "Wang S.S., Zhang Q.L., Chu P., Kong L.Q., Li G.Z., Li Y.Q., Yang L., Zhao X.J., Guo X.H., Tang Z.Y. Synthesis and antitumor activity of \u03b1, \u03b2-unsaturated carbonyl moiety- containing oleanolic acid derivatives targeting PI3K/AKT/mTOR signaling pathway. Bioorg. Chem. 2020;101:104036. doi: 10.1016/j.bioorg.2020.104036.", "ArticleIdList": ["10.1016/j.bioorg.2020.104036", "32629283"]}, {"Citation": "Shan Y., Guan F., Zhao X., Wang M., Chen Y., Wang Q., Feng X. Macranthoside B Induces Apoptosis and Autophagy Via Reactive Oxygen Species Accumulation in Human Ovarian Cancer A2780 Cells. Nutr. Cancer. 2016;68:280\u2013289. doi: 10.1080/01635581.2016.1142587.", "ArticleIdList": ["10.1080/01635581.2016.1142587", "26943028"]}, {"Citation": "Zheng K., He Z., Kitazato K., Wang Y. Selective Autophagy Regulates Cell Cycle in Cancer Therapy. Theranostics. 2019;9:104\u2013125. doi: 10.7150/thno.30308.", "ArticleIdList": ["10.7150/thno.30308", "PMC6332805", "30662557"]}, {"Citation": "Kim G.-J., Jo H.-J., Lee K.-J., Choi J.W., An J.H. Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice. Oncotarget. 2018;9:26370\u201326386. doi: 10.18632/oncotarget.25316.", "ArticleIdList": ["10.18632/oncotarget.25316", "PMC5995180", "29899865"]}, {"Citation": "Wang H., Zhong W., Zhao J., Zhang H., Zhang Q., Liang Y., Chen S., Liu H., Zong S., Tian Y., et al. Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization. Mol. Cancer. Ther. 2019;18:62\u201374. doi: 10.1158/1535-7163.MCT-18-0448.", "ArticleIdList": ["10.1158/1535-7163.MCT-18-0448", "30297361"]}, {"Citation": "Modica-Napolitano J.S., Aprille J.R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug. Deliv. Rev. 2001;49:63\u201370. doi: 10.1016/S0169-409X(01)00125-9.", "ArticleIdList": ["10.1016/S0169-409X(01)00125-9", "11377803"]}, {"Citation": "Modica-Napolitano J.S., Aprille J.R. Basis for the selective cytotoxicity of rhodamine 123. Cancer Res. 1987;47:4361\u20134365.", "ArticleIdList": ["2886218"]}, {"Citation": "Cai H., Zhang Y., Han T.K., Everett R.S., Thakker D.R. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells. Int. J. Cancer. 2016;138:2281\u20132292. doi: 10.1002/ijc.29965.", "ArticleIdList": ["10.1002/ijc.29965", "26669511"]}, {"Citation": "Brown K.K., Spinelli J.B., Asara J.M., Toker A. Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer. Cancer Discov. 2017;7:391\u2013399. doi: 10.1158/2159-8290.CD-16-0611.", "ArticleIdList": ["10.1158/2159-8290.CD-16-0611", "PMC5380483", "28255083"]}, {"Citation": "Wang Z., Jiang Q., Dong C. Metabolic reprogramming in triple-negative breast cancer. Cancer Biol. Med. 2020;17:44\u201359. doi: 10.20892/j.issn.2095-3941.2019.0210.", "ArticleIdList": ["10.20892/j.issn.2095-3941.2019.0210", "PMC7142847", "32296576"]}, {"Citation": "Shi X., Zhang T., Lou H., Song H., Li C., Fan P. Anticancer Effects of Honokiol via Mitochondrial Dysfunction Are Strongly Enhanced by the Mitochondria-Targeting Carrier Berberine. J. Med. Chem. 2020;63:11786\u201311800. doi: 10.1021/acs.jmedchem.0c00881.", "ArticleIdList": ["10.1021/acs.jmedchem.0c00881", "32996316"]}, {"Citation": "Friedrich S., Serbian I., Hoenke S., Wolfram R.K., Csuk R. Synthesis and cytotoxic evaluation of malachite green derived oleanolic and ursolic acid piperazineamides. Med. Chem. Res. 2020;29:926\u2013933. doi: 10.1007/s00044-020-02536-1.", "ArticleIdList": ["10.1007/s00044-020-02536-1"]}, {"Citation": "Xie C., Chang J., Hao X.-D., Yu J.-M., Liu H.-R., Sun X. Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel. Pt AEur. J. Pharm. Biopharm. 2013;85:541\u2013549. doi: 10.1016/j.ejpb.2013.06.008.", "ArticleIdList": ["10.1016/j.ejpb.2013.06.008", "23791719"]}, {"Citation": "Sommerwerk S., Heller L., Kerzig C., Kramell A.E., Csuk R. Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations. Eur. J. Med. Chem. 2017;127:1\u20139. doi: 10.1016/j.ejmech.2016.12.040.", "ArticleIdList": ["10.1016/j.ejmech.2016.12.040", "28033541"]}, {"Citation": "Wolfram R.K., Fischer L., Kluge R., Str\u00f6hl D., Al-Harrasi A., Csuk R. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans. Eur. J. Med. Chem. 2018;155:869\u2013879. doi: 10.1016/j.ejmech.2018.06.051.", "ArticleIdList": ["10.1016/j.ejmech.2018.06.051", "29960206"]}, {"Citation": "Heise N., Hoenke S., Simon V., Deigner H.-P., Al-Harrasi A., Csuk R. Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids. Steroids. 2021;172:108876. doi: 10.1016/j.steroids.2021.108876.", "ArticleIdList": ["10.1016/j.steroids.2021.108876", "34129861"]}, {"Citation": "Masullo M., Pizza C., Piacente S. Oleanane derivatives for pharmaceutical use: A patent review (2000\u20132016) Expert Opin. Ther. Pat. 2017;27:237\u2013255. doi: 10.1080/13543776.2017.1253680.", "ArticleIdList": ["10.1080/13543776.2017.1253680", "27782764"]}, {"Citation": "Inoue S., Snowden R.T., Dyer M., Cohen G.M. CDDO induces apoptosis via the intrinsic pathway in lymphoid cells. Leukemia. 2004;18:948\u2013952. doi: 10.1038/sj.leu.2403328.", "ArticleIdList": ["10.1038/sj.leu.2403328", "14990979"]}, {"Citation": "Ju W., Li N., Wang J., Yu N., Lei Z., Zhang L., Sun J., Chen L. Design and synthesis of novel mitochondria-targeted CDDO derivatives as potential anti-cancer agents. Bioorg. Chem. 2021;115:105249. doi: 10.1016/j.bioorg.2021.105249.", "ArticleIdList": ["10.1016/j.bioorg.2021.105249", "34390971"]}, {"Citation": "Spivak A., Khalitova R., Nedopekina D., Dzhemileva L., Yunusbaeva M., Odinokov V., D\u2019yakonov V., Dzhemilev U. Synthesis and Evaluation of Anticancer Activities of Novel C-28 Guanidine-Functionalized Triterpene Acid Derivatives. Molecules. 2018;23:3000. doi: 10.3390/molecules23113000.", "ArticleIdList": ["10.3390/molecules23113000", "PMC6278366", "30453551"]}, {"Citation": "Fan J.P., Lai X.H., Zhang X.H., Yang L., Yuan T.T., Chen H.P., Liang X. Synthesis and evaluation of the cancer cell growth inhibitory activity of the ionic derivatives of oleanolic acid and ursolic acid with improved solubility. J. Mol. Liq. 2021;332:115837. doi: 10.1016/j.molliq.2021.115837.", "ArticleIdList": ["10.1016/j.molliq.2021.115837"]}, {"Citation": "Biswas T., Dwivedi U.N. Plant triterpenoid saponins: Biosynthesis, in vitro production, and pharmacological relevance. Protoplasma. 2019;256:1463\u20131486. doi: 10.1007/s00709-019-01411-0.", "ArticleIdList": ["10.1007/s00709-019-01411-0", "31297656"]}, {"Citation": "Xiao G., Shao X., Zhu D., Yu B. Chemical Synthesis of Marine Saponins. Nat. Prod. Rep. 2019;36:769\u2013787. doi: 10.1039/C8NP00087E.", "ArticleIdList": ["10.1039/C8NP00087E", "30525166"]}, {"Citation": "Wang L., Yang B., Lin X.P., Zhou X.F., Liu Y. Sesterterpenoids. Nat. Prod. Rep. 2013;30:455\u2013473. doi: 10.1039/c3np20089b.", "ArticleIdList": ["10.1039/c3np20089b", "23385977"]}, {"Citation": "Krief S., Thoison O., S\u00e9venet T., Wrangham R.W., Lavaud C. Triterpenoid saponin anthranilates from Albizia grandibracteata leaves ingested by primates in Uganda. J. Nat. Prod. 2005;68:897\u2013903. doi: 10.1021/np049576i.", "ArticleIdList": ["10.1021/np049576i", "15974615"]}, {"Citation": "Liu Q., Liu H., Zhang L., Guo T., Wang P., Geng M., Li Y. Synthesis and anti-tumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives. Eur. J. Med. Chem. 2013;64:1\u201315. doi: 10.1016/j.ejmech.2013.04.016.", "ArticleIdList": ["10.1016/j.ejmech.2013.04.016", "23639650"]}, {"Citation": "Juang Y.P., Liang P.H. Biological and Pharmacological Effects of Synthetic Saponins. Molecules. 2020;25:4974. doi: 10.3390/molecules25214974.", "ArticleIdList": ["10.3390/molecules25214974", "PMC7663351", "33121124"]}, {"Citation": "Fang Y., Yang Z., Ouyang H., Wang R., Li J., Huang H., Jin Y., Feng Y., Yang S. Synthesis and biological evaluation of Hederacolchiside A1 derivatives as anticancer agents. Bioorg. Med. Chem. Lett. 2016;26:4576\u20134579. doi: 10.1016/j.bmcl.2016.08.077.", "ArticleIdList": ["10.1016/j.bmcl.2016.08.077", "27592134"]}, {"Citation": "Chen Z., Duan H., Wang M., Han L., Liu Y., Zhu Y., Yang S. Synthesis, cytotoxicity and haemolytic activity of Pulsatilla saponin A, D derivatives. Bioorg. Med. Chem. Lett. 2015;25:2550\u20132554. doi: 10.1016/j.bmcl.2015.04.049.", "ArticleIdList": ["10.1016/j.bmcl.2015.04.049", "25958248"]}, {"Citation": "Abdel-Aziz M., Abuo-Rahma G.E.-D., Beshr E.A., Ali T. New nitric oxide donating 1,2,4-triazole/oxime hybrids: Synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities. Bioorg. Med. Chem. 2013;21:3839\u20133849. doi: 10.1016/j.bmc.2013.04.022.", "ArticleIdList": ["10.1016/j.bmc.2013.04.022", "23665142"]}, {"Citation": "Zou Y., Yan C., Liu J.-C., Huang Z.-J., Xu J.-Y., Zhou J.-P., Zhang H.-B., Zhang Y.-H. Synthesis and anti-hepatocellular carcinoma activity of novel O2-vinyl diazeniumdiolate-based nitric oxide-releasing derivatives of oleanolic acid. Chin. J. Nat. Med. 2017;15:928\u2013937.", "ArticleIdList": ["29329650"]}, {"Citation": "Fang Y., Wang R., He M., Huang H., Wang Q., Yang Z., Li Y., Yang S., Jin Y. Nitric oxide-donating derivatives of hederacolchiside A1: Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents. Bioorg. Med. Chem. Lett. 2017;27:98\u2013101. doi: 10.1016/j.bmcl.2016.11.021.", "ArticleIdList": ["10.1016/j.bmcl.2016.11.021", "27866816"]}, {"Citation": "Hamed A.I., Piacente S., Autore G., Marzocco S., Pizza C., Oleszek W. Antiproliferative hopane and oleanane glycosides from the roots of Glinus lotoides. Planta Med. 2005;71:554\u2013560. doi: 10.1055/s-2005-864158.", "ArticleIdList": ["10.1055/s-2005-864158", "15971128"]}, {"Citation": "Wei G., Cui S., Luan W., Wang S., Hou Z., Liu Y., Liu Y., Cheng M. Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death. Eur. J. Med. Chem. 2016;113:92\u2013101. doi: 10.1016/j.ejmech.2015.12.034.", "ArticleIdList": ["10.1016/j.ejmech.2015.12.034", "26922223"]}, {"Citation": "Zhang H., Samadi A.K., Rao K.V., Cohen M.S., Timmermann B.N. Cytotoxic oleanane-type saponins from Albizia inundata. J. Nat. Prod. 2011;74:477\u2013482. doi: 10.1021/np100702p.", "ArticleIdList": ["10.1021/np100702p", "PMC3090140", "21314099"]}, {"Citation": "Wang L., Wang Z., Su S., Xing Y., Li Y., Li M., Liu J., Yang S. Synthesis and cytotoxicity of oleanolic acid trisaccharide saponins. Carbohydr. Res. 2017;442:9\u201316. doi: 10.1016/j.carres.2017.02.010.", "ArticleIdList": ["10.1016/j.carres.2017.02.010", "28273565"]}, {"Citation": "Seo Y., Hoch J., Abdel-Kader M., Malone S., Derveld I., Adams H., Werkhoven M.C.M., Wisse J.H., Mamber S.W., Dalton J.M., et al. Bioactive saponins from Acacia tenuifolia from the suriname rainforest. J. Nat. Prod. 2002;65:170\u2013174. doi: 10.1021/np0103620.", "ArticleIdList": ["10.1021/np0103620", "11858750"]}, {"Citation": "Yan M.C., Liu Y., Chen H., Ke Y., Xu Q.C., Cheng M.S. Synthesis and anti-tumor activity of two natural N-acetylglucosamine-bearing triterpenoid saponins: Lotoidoside D and E. Bioorg. Med. Chem. Lett. 2006;16:4200\u20134204. doi: 10.1016/j.bmcl.2006.05.086.", "ArticleIdList": ["10.1016/j.bmcl.2006.05.086", "16765595"]}, {"Citation": "Lin Y.-Y., Chan S.-H., Juang Y.-P., Hsiao H.-M., Guh J.-H., Liang P.-H. Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine. Eur. J. Med. Chem. 2018;143:1942\u20131958. doi: 10.1016/j.ejmech.2017.11.004.", "ArticleIdList": ["10.1016/j.ejmech.2017.11.004", "29133061"]}, {"Citation": "Juang Y.-P., Lin Y.-Y., Chan S.-H., Chang C.-K., Shie J.-J., Hsieh Y.S., Guh J.-H., Liang P.-H. Synthesis, distribution analysis and mechanism studies of N-acyl glucosamine-bearing oleanolic saponins. Bioorg. Chem. 2020;99:103835. doi: 10.1016/j.bioorg.2020.103835.", "ArticleIdList": ["10.1016/j.bioorg.2020.103835", "32305695"]}, {"Citation": "Jung H.-J., Lee C.O., Lee K.-T., Choi J., Park H.-J. Structure-activity relationship of oleanane disaccharides isolated from Akebia quinata versus cytotoxicity against cancer cells and NO inhibition. Biol. Pharm. Bull. 2004;27:744\u2013747. doi: 10.1248/bpb.27.744.", "ArticleIdList": ["10.1248/bpb.27.744", "15133259"]}, {"Citation": "Wang Z., Shen J., Sun W., Zhang T., Zuo D., Wang H., Wang G., Xu J., Yin F., Mao M., et al. Anti-tumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma. Cancer Sci. 2019;110:1746\u20131759. doi: 10.1111/cas.14008.", "ArticleIdList": ["10.1111/cas.14008", "PMC6500987", "30907478"]}, {"Citation": "Li H.N., Wang H., Wang Z.P., Yan H.N., Zhang M., Liu Y., Cheng M.S. Synthesis, anti-tumor activity evaluation and mechanistic study of novel hederacolchiside A1 derivatives bearing an aryl triazole moiety. Bioorg. Med. Chem. 2018;26:4025\u20134033. doi: 10.1016/j.bmc.2018.06.026.", "ArticleIdList": ["10.1016/j.bmc.2018.06.026", "29958763"]}, {"Citation": "Zhong Y., Li H.N., Zhou L., Su H.S., Cheng M.S., Liu Y. Synthesis and anti-tumor activity evaluation of oleanolic acid saponins bearing an acetylated l-arabinose moiety. Carbohydr. Res. 2021;503:108311. doi: 10.1016/j.carres.2021.108311.", "ArticleIdList": ["10.1016/j.carres.2021.108311", "33866267"]}, {"Citation": "Soica C., Trandafirescu C., Danciu C., Muntean D., Dehelean C., Simu G. New improved drug delivery technologies for pentacyclic triterpenes: A review. Protein Pept. Lett. 2014;21:1137\u20131145. doi: 10.2174/0929866521666140807115109.", "ArticleIdList": ["10.2174/0929866521666140807115109", "25106907"]}, {"Citation": "Alvarado H.L., Abrego G., Gardu\u00f1o-Ramirez M.L., Clares B., Calpena A.C., Garc\u00eda M.L. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomedicine. 2015;11:521\u2013530. doi: 10.1016/j.nano.2015.01.004.", "ArticleIdList": ["10.1016/j.nano.2015.01.004", "25659643"]}, {"Citation": "Man D.K.W., Casettari L., Cespi M., Bonacucina G., Palmieri G.F., Sze S.C.W., Leung G.P.H., Lam J., Kwok P.C.L. Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells. Mol. Pharm. 2015;12:2112\u20132125. doi: 10.1021/acs.molpharmaceut.5b00085.", "ArticleIdList": ["10.1021/acs.molpharmaceut.5b00085", "25881668"]}, {"Citation": "Medina-O\u2019Donnell M., Rivas F., Reyes-Zurita F.J., Martinez A., Martin-Fonseca S., Garcia-Granados A., Ferrer-Mart\u00edn R.M., Lupianez J.A., Parra A. Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes. Eur. J. Med. Chem. 2016;118:64\u201378. doi: 10.1016/j.ejmech.2016.04.016.", "ArticleIdList": ["10.1016/j.ejmech.2016.04.016", "27128174"]}, {"Citation": "Abuchowski A., McCoy J.R., Palczuk N.C., van Es T., Davis F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977;252:3582\u20133586. doi: 10.1016/S0021-9258(17)40292-4.", "ArticleIdList": ["10.1016/S0021-9258(17)40292-4", "16907"]}, {"Citation": "Heller L., Knorrscheidt A., Flemming F., Wiemann J., Sommerwerk S., Pavel I.Z., Al-Harrasi A., Csuk R. Synthesis and proapoptotic activity of oleanolic acid derived amides. Bioorg. Chem. 2016;68:137\u2013151. doi: 10.1016/j.bioorg.2016.08.004.", "ArticleIdList": ["10.1016/j.bioorg.2016.08.004", "27518757"]}, {"Citation": "Jannus F., Medina-O\u2019Donnell M., Rivas F., D\u00edaz-Ruiz L., Rufino-Palomares E.E., Lupi\u00e1\u00f1ez J.A., Parra A., Reyes-Zurita F.J. A Diamine-PEGylated Oleanolic Acid Derivative Induced Efficient Apoptosis through a Death Receptor and Mitochondrial Apoptotic Pathway in HepG2 Human Hepatoma Cells. Biomolecules. 2020;10:1375. doi: 10.3390/biom10101375.", "ArticleIdList": ["10.3390/biom10101375", "PMC7601263", "32998255"]}, {"Citation": "Kahnt M., Loesche A., Serbian I., Hoenke S., Fischer L., Al-Harrasi A., Csuk R. The cytotoxicity of oleanane derived aminocarboxamides depends on their aminoalkyl substituents. Steroids. 2019;149:108422. doi: 10.1016/j.steroids.2019.05.014.", "ArticleIdList": ["10.1016/j.steroids.2019.05.014", "31175922"]}, {"Citation": "Feng B., Zhao C., Li J., Yu J., Zhang Y., Zhang X., Tian T., Zhao L. The Novel Synthetic Triterpene Methyl 3\u03b2-O-[4-(2-Aminoethylamino)-4-oxo-butyryl] olean-12-ene-28-oate Inhibits Breast Tumor Cell Growth in Vitro and in Vivo. Chem. Pharm. Bull. 2020;68:962\u2013970. doi: 10.1248/cpb.c20-00353.", "ArticleIdList": ["10.1248/cpb.c20-00353", "32999148"]}, {"Citation": "Li W., Elhassan R.M., Hou X., Fang H. Recent Advances in Small Molecule PROTACs for the Treatment of Cancer. Curr. Med. Chem. 2021;28:4893\u20134909. doi: 10.2174/0929867327666201117141611.", "ArticleIdList": ["10.2174/0929867327666201117141611", "33208057"]}, {"Citation": "Wu T., Yoon H., Xiong Y., Dixon-Clarke S.E., Nowak R.P., Fischer E.S. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery. Nat. Struct. Mol. Biol. 2020;27:605\u2013614. doi: 10.1038/s41594-020-0438-0.", "ArticleIdList": ["10.1038/s41594-020-0438-0", "PMC7923177", "32541897"]}, {"Citation": "Spradlin J.N., Hu X., Ward C.C., Brittain S.M., Jones M.D., Ou L., To M., Proudfoot A., Ornelas E., Woldegiorgis M., et al. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation. Nat. Chem. Biol. 2019;15:747\u2013755. doi: 10.1038/s41589-019-0304-8.", "ArticleIdList": ["10.1038/s41589-019-0304-8", "PMC6592714", "31209351"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "23"}, {"Year": "2022", "Month": "10", "Day": "24"}, {"Year": "2022", "Month": "10", "Day": "28"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "27"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["36362079", "PMC9656325", "10.3390/ijms232113291", "ijms232113291"]}}], "PubmedBookArticle": []}